Suggestions
Dan Freed
Head of Target Discovery and Translational Research
Dan Freed is the Head of Target Discovery and Translational Research at the Chordoma Foundation, a position he has held since December 2020. In this role, he serves as the principal investigator at CF Labs, which focuses on patient-centric target validation and translational research for chordoma, a rare type of cancer. His responsibilities include managing projects aimed at identifying new therapeutic targets, translating biological insights into therapeutic hypotheses, and overseeing a biobank for chordoma biospecimens.12
Freed has a strong background in structural and molecular biology, biochemistry, cancer biology, and drug discovery. He aims to develop therapeutic strategies by identifying vulnerabilities in cancer cells. His previous roles include positions at G1 Therapeutics, where he worked in translational medicine, and as a postdoctoral fellow at the University of Pennsylvania.12
He earned his PhD from the University of Virginia and holds a Bachelor of Science from the University of North Carolina at Wilmington. Additionally, he has received an NIH Postdoctoral Fellowship during his academic career.1
